Exercise midregional pro-atrial natriuretic peptide (MR-proANP) as a potential diagnostic tool to identify dynamic mitral regurgitation

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

About the speaker

Doctor Steffen D Kriechbaum

Kerckhoff Heart and Thorax Center, Bad Nauheim (Germany)

7 More presentations in this session

Presentation thumbnail

Discussant - Treatment and outcome of mitral valve regurgitation

Presentation thumbnail

Concomitant mitral regurgitation is associated with worse outcomes after T-TEER: insights from the EuroTR registry

Doctor D. Felbel (Ulm, DE)

Presentation thumbnail

Echocardiographic insights: factors influencing mitral regurgitation in fabry disease

Doctor A. Vecerova (Prague, CZ)

Presentation thumbnail

Key predictors of non-interventional mitral regurgitation improvement: Insights from the SHEBAHEART registry

Doctor S. Elimeleh (Ramat Gan, IL)

Presentation thumbnail

The role of NT ProBNP and Galectin 3 in the follow up of patients with primary mitral regurgitation

Doctor C. Riebel (Cluj Napoca, RO)

Access the full session

Session thumbnail

New perspectives in cardiology (3) - Treatment and outcome of mitral valve regurgitation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Prognostic impact of resting and exercise right ventricular to pulmonary artery coupling in patients with dynamic mitral regurgitation

Congress Presentation

The effect of exercise on RV-PC coupling in asymptomatic patients with significant primary mitral regurgitation

Congress Presentation

Secondary mitral regurgitation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources